Revive Therapeutics (XCNQ:RVV) Scaled Net Operating Assets : 0.65 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Revive Therapeutics's operating assets for the quarter that ended in Dec. 2023 was C$12.17 Mil. Revive Therapeutics's operating liabilities for the quarter that ended in Dec. 2023 was C$3.19 Mil. Revive Therapeutics's Total Assets for the quarter that ended in Sep. 2023 was C$13.78 Mil. Therefore, Revive Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.65.

Revive Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Revive Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Scaled Net Operating Assets Chart

Revive Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.43

5.00

1.53

0.30

0.52

Revive Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.57	0.62	0.64	0.62	0.65

Competitive Comparison of Revive Therapeutics's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revive Therapeutics's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Revive Therapeutics's Scaled Net Operating Assets falls into.

Revive Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Revive Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2023 )
=	(Operating Assets (A: Jun. 2023 )	-	Operating Liabilities (A: Jun. 2023 ))	/	Total Assets (A: Jun. 2022 )
=	(12.165	-	3.38)	/	17.065
=	0.51

where

	Operating Assets		(A: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	14.252	-	2.087
=	12.165

	Operating Liabilities		(A: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.599	-	0.085	-	0.134
=	3.38

Revive Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(12.169	-	3.19)	/	13.78
=	0.65

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	12.877	-	0.708
=	12.169

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.346	-	0.06	-	0.096
=	3.19

Revive Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (XCNQ:RVV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

RVVTF:USA 31R:Germany

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Executives

Michael Frank

Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines